Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Hank Payments Achieves Record Growth in its Profitable Auto Channel (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s):  XRTX

Healthcare
XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance... see more

TSXV:XRTX - Post Discussion

XORTX Therapeutics Inc > Dr. Xortx is Stepping Down the CEO, about time.
View:
Post by SpaceLabs on Jan 13, 2022 12:04am

Dr. Xortx is Stepping Down the CEO, about time.

He has no BROAD Experience as CEO and a bumpy Scientist who needs to act fast . He has been seen as a LIAR and shre  ROLLBACK KING so far.

He has his steps to follow to do the RIGHT THING for the SHAREHOLDERS !,,,,pls GO !
Comment by Moonrunner on Jan 13, 2022 12:51pm
Where did you read he was stepping down?.
Comment by SpaceLabs on Jan 13, 2022 3:22pm
Written all over his face after Nasdaq listing. Share prc Tanked and this guy is UNFIT as a CEO, Back he goes to the Scientific Board to get the product out. He is trying too hard and no one on WALL STREET respects him as XRX CEO, we need a Business Management CEO who has connections on Wall St. to take XRX after MASSIVE ROLLBACK with only 13M shares. JPM knows they have an unqulified CEO ...more  
Comment by gossamer5 on Jan 24, 2022 9:26pm
This post has been removed in accordance with Community Policy
XORTX Therapeutics Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities